Published in J Wildl Dis on January 01, 2013
Construction and characterization of E1- and E3-deleted adenovirus vectors expressing two antigens from two separate expression cassettes. Hum Gene Ther (2014) 0.77
Field Trial of an Aerially-Distributed Tuberculosis Vaccine in a Low-Density Wildlife Population of Brushtail Possums (Trichosurus vulpecula). PLoS One (2016) 0.75
Management and modeling approaches for controlling raccoon rabies: The road to elimination. PLoS Negl Trop Dis (2017) 0.75
An oral Aujeszky's disease vaccine (YS-400) induces neutralizing antibody in pigs. Clin Exp Vaccine Res (2016) 0.75
Bat white-nose syndrome: an emerging fungal pathogen? Science (2008) 6.32
Morphological and molecular characterizations of psychrophilic fungus Geomyces destructans from New York bats with White Nose Syndrome (WNS). PLoS One (2010) 1.91
Current and future trends in the prevention, treatment and control of rabies. Expert Rev Anti Infect Ther (2006) 1.43
National surveillance for human and pet contact with oral rabies vaccine baits, 2001-2009. J Am Vet Med Assoc (2012) 1.39
Influenza infection in wild raccoons. Emerg Infect Dis (2008) 1.30
Clonal genotype of Geomyces destructans among bats with White Nose Syndrome, New York, USA. Emerg Infect Dis (2011) 1.25
Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl Trop Dis (2009) 1.21
Development of a GIS-based, real-time Internet mapping tool for rabies surveillance. Int J Health Geogr (2006) 1.21
Direct and indirect costs of rabies exposure: a retrospective study in southern California (1998-2002). J Wildl Dis (2007) 1.13
Tactics and economics of wildlife oral rabies vaccination, Canada and the United States. Emerg Infect Dis (2009) 1.05
Comparing ONRAB® AND RABORAL V-RG® oral rabies vaccine field performance in raccoons and striped skunks, New Brunswick, Canada, and Maine, USA. J Wildl Dis (2012) 0.95
Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs. PLoS Negl Trop Dis (2009) 0.94
High concentrations of persistent organic pollutants including PCBs, DDT, PBDEs and PFOS in little brown bats with white-nose syndrome in New York, USA. Chemosphere (2010) 0.91
Structuring targeted surveillance for monitoring disease emergence by mapping observational data onto ecological process. J R Soc Interface (2013) 0.90
Rapid real-time PCR assay for culture and tissue identification of Geomyces destructans: the etiologic agent of bat geomycosis (white nose syndrome). Mycopathologia (2011) 0.88
Effects of aerosolized rabies virus exposure on bats and mice. J Infect Dis (2007) 0.88
Benefit cost scenarios of potential oral rabies vaccination for skunks in California. J Wildl Dis (2009) 0.86
Concomitant administration of GonaCon™ and rabies vaccine in female dogs (Canis familiaris) in Mexico. Vaccine (2013) 0.82
Skunk rabies in California (1992-2003)--implications for oral rabies vaccination. J Wildl Dis (2008) 0.82
Rabies virus infection in Eptesicus fuscus bats born in captivity (naïve bats). PLoS One (2013) 0.81
Potential effect of prior raccoonpox virus infection in raccoons on vaccinia-based rabies immunization. BMC Immunol (2008) 0.81
A new flavor-coated sachet bait for delivering oral rabies vaccine to raccoons and coyotes. J Wildl Dis (2002) 0.81
Susceptibility and pathogenesis of little brown bats (Myotis lucifugus) to heterologous and homologous rabies viruses. J Virol (2013) 0.81
Extended incubation period of rabies virus in a captive big brown bat (Eptesicus fuscus). J Wildl Dis (2012) 0.80
Oral rabies vaccination of raccoons and striped skunks with ONRAB® baits: multiple factors influence field immunogenicity. J Wildl Dis (2012) 0.80
Influence of oral rabies vaccine bait density on rabies seroprevalence in wild raccoons. Vaccine (2009) 0.80
Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine. Vaccine (2009) 0.79
Antigenic characterisation of lyssaviruses in South Africa. Onderstepoort J Vet Res (2014) 0.79
Lyssaviruses: current trends. Adv Virus Res (2008) 0.78
Characterization of a panel of anti-phosphoprotein monoclonal antibodies generated against the raccoon strain of rabies virus. Virus Res (2010) 0.77
Rabies virus infection in a pet guinea pig and seven pet rabbits. J Am Vet Med Assoc (2005) 0.77
Characterizing rabies epidemiology in remote Inuit communities in Québec, Canada: a "One Health" approach. Ecohealth (2014) 0.77
Stability of vaccinia-vectored recombinant oral rabies vaccine under field conditions: a 3-year study. Can J Vet Res (2011) 0.76
No adverse effects of simultaneous vaccination with the immunocontraceptive GonaCon and a commercial rabies vaccine on rabies virus neutralizing antibody production in dogs. Vaccine (2009) 0.76
Costs of raccoon rabies incidents in cattle herds in Hampshire County, West Virginia, and Guernsey County, Ohio. J Am Vet Med Assoc (2013) 0.75
Bat rabies and human postexposure prophylaxis, New York, USA. Emerg Infect Dis (2011) 0.75
Antigen detection, rabies virus isolation, and Q-PCR in the quantification of viral load in a natural infection of the North American beaver (Castor canadensis). J Wildl Dis (2015) 0.75
Oral rabies vaccination variation in tetracycline biomarking among Ohio raccoons. J Wildl Dis (2013) 0.75